AAAAAA

   
Results: 1-8 |
Results: 8
Clinical and sensorimotor gating effects of ketamine in normals
Authors: Duncan, EJ Madonick, SH Parwani, A Angrist, B Rajan, R Chakravorty, S Efferen, TR Szilagyi, S Stephanides, M Chappell, PB Gonzenbach, S Ko, GN Rotrosen, JP
Citation: Ej. Duncan et al., Clinical and sensorimotor gating effects of ketamine in normals, NEUROPSYCH, 25(1), 2001, pp. 72-83
A placebo-controlled study of guanfacine in the treatment of children withtic disorders and attention deficit hyperactivity disorder
Authors: Scahill, L Chappell, PB Kim, YS Schultz, RT Katsovich, L Shepherd, E Arnsten, AFT Cohen, DJ Leckman, JF
Citation: L. Scahill et al., A placebo-controlled study of guanfacine in the treatment of children withtic disorders and attention deficit hyperactivity disorder, AM J PSYCHI, 158(7), 2001, pp. 1067-1074
Pharmacologic treatment of tic disorders
Authors: Scahill, L Chappell, PB King, RA Leckman, JF
Citation: L. Scahill et al., Pharmacologic treatment of tic disorders, CH ADOLESC, 9(1), 2000, pp. 99
Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study
Authors: Sallee, FR Kurlan, R Goetz, CG Singer, H Scahill, L Law, G Dittman, VM Chappell, PB
Citation: Fr. Sallee et al., Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study, J AM A CHIL, 39(3), 2000, pp. 292-299
Patterns of response to acute naloxone infusion in Tourette's syndrome
Authors: van Wattum, PJ Chappell, PB Zelterman, D Scahill, LD Leckman, JF
Citation: Pj. Van Wattum et al., Patterns of response to acute naloxone infusion in Tourette's syndrome, MOVEMENT D, 15(6), 2000, pp. 1252-1254
Impaired prepulse inhibition of acoustic startle in schizophrenia
Authors: Parwani, A Duncan, EJ Bartlett, E Madonick, SH Efferen, TR Rajan, R Sanfilipo, M Chappell, PB Chakravorty, S Gonzenbach, S Ko, GN Rotrosen, JP
Citation: A. Parwani et al., Impaired prepulse inhibition of acoustic startle in schizophrenia, BIOL PSYCHI, 47(7), 2000, pp. 662-669
Cerebrospinal fluid dynorphin A 1-80RSQB; and beta-endorphin levels in Tourette's syndrome are unaltered (vol 45, pg 1527, 1999)
Authors: van Wattum, PJ Anderson, GM Chappell, PB Goodman, WK Riddle, MA Leckman, JF
Citation: Pj. Van Wattum et al., Cerebrospinal fluid dynorphin A 1-80RSQB; and beta-endorphin levels in Tourette's syndrome are unaltered (vol 45, pg 1527, 1999), BIOL PSYCHI, 46(10), 1999, pp. 1455-1455
Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered
Authors: van Wattum, PJ Anderson, GM Chappell, PB Goodman, WK Riddle, MA Leckman, JF
Citation: Pj. Van Wattum et al., Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered, BIOL PSYCHI, 45(11), 1999, pp. 1527-1528
Risultati: 1-8 |